RS

Rahul Shrikant Mahamuni

Active Director Director DIN 10717463
DIN 10717463 First appointment Jul 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rahul Shrikant Mahamuni

Data last updated:

Rahul Shrikant Mahamuni is a Director at Deccan Elite Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 10717463
Primary Designation Director
Industry Healthcare
First Appointment 31 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Deccan Elite Hospital Private Limited
Premium access

Shareholding and investment profile for Rahul Shrikant Mahamuni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Shrikant Mahamuni

Rahul Shrikant Mahamuni currently holds 1 directorship: Deccan Elite Hospital Private Limited (Director, since 31 Jul 2024).

Rahul Shrikant Mahamuni was first appointed on 31 Jul 2024 as Director at Deccan Elite Hospital Private Limited.

The current boards of Rahul Shrikant Mahamuni's companies include Amol Shivaji Chavan (Deccan Elite Hospital Private Limited), Anil Rajaram Naikawadi (Deccan Elite Hospital Private Limited), Mukul Milind Patil (Deccan Elite Hospital Private Limited), Pushkar Sudhir Borole (Deccan Elite Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available